Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

NCT00070018

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States
View all 48 locations
View Trial Details
Completed

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

NCT00865969

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Wilshire Oncology Medical Group, Inc La Verne, California, United States
  • Comprehensive Cancer Center Palm Springs, California, United States
  • Yale Cancer Center-Section of Medical Oncology New Haven, Connecticut, United States
View all 117 locations
View Trial Details
Completed

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

NCT02733458

Conditions
Extranodal NK-T-Cell Lymphoma, Nasal Type, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations
  • Shanghai Dong Fang hospital Shanghai, Shanghai Municipality, China
  • Department of Hematology, Renji Hospital Shanghai, Shanghai Municipality, China
  • South Renji hospital Shanghai, Shanghai Municipality, China
  • Xin Jiang People's Hospital Ürümqi, Xinjiang, China
View Trial Details
Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT01767766

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • TG Therapeutics Trial Site Sarasota, Florida, United States
  • TG Therapeutics Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Trial Site New York, United States
  • TG Therapeutics Trial Site Durham, North Carolina, United States
View Trial Details
Completed

Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

NCT00425555

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Alabama at Birmingham/ Kirklin Clinic Kirklin Clinic Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Dept. of Hematology-Oncology Los Angeles, California, United States
  • Florida Academic Dermatology Center Miami, Florida, United States
View all 42 locations
View Trial Details

Related conditions